JERSEY CITY – November 02, 2026 -- ABVC BioPharma (NASDAQ: ABVC) has closed a private placement of original issue discount senior convertible promissory notes that generated approximately $3.39 million in gross proceeds, before placement agent fees and offering expenses, WallachBeth Capital LLC announced.

Notes carry $4.1 million principal and a June 2027 maturity

The 17.5% OID Notes have an aggregate principal amount of $4,106,060 and mature on June 30, 2027. Investors in the securities purchase agreement are institutional and other accredited investors.